中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共191条,第1-10条 帮助

条数/页: 排序方式:
Pharmacokinetic and metabolite profile of orally administered anemoside B4 in rats with an improved exposure in formulations of rectal suppository 期刊论文  OAI收割
JOURNAL OF ETHNOPHARMACOLOGY, 2023, 卷号: 315, 页码: 11
作者:  
Ye, Yaqing;  Xue, Mingzhen;  Tian, Xiaoting;  Gao, Hongwei;  Hu, Pei
  |  收藏  |  浏览/下载:10/0  |  提交时间:2023/10/17
Pharmacokinetics,mass balance,and metabolism of 14C TPN171,a novel PDE5 inhibitor,in humans for the treatment of pulmonary arterial hypertension 期刊论文  OAI收割
ACTA PHARMACOLOGICA SINICA, 2023, 卷号: 44, 期号: 1, 页码: 221
作者:  
He Yifei;  Liu Yin;  Yu Jinghua;  Cheng Huan;  Odilov Abdullajon
  |  收藏  |  浏览/下载:15/0  |  提交时间:2023/05/22
Inhibition of estrogen sulfation by Xian-Ling-Gu-Bao capsule 期刊论文  OAI收割
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2023, 卷号: 225, 页码: 12
作者:  
He, Liangliang;  Chen, Chanjuan;  Duan, Shuyi;  Li, Yang;  Li, Chuan
  |  收藏  |  浏览/下载:29/0  |  提交时间:2022/11/11
Changes in Disposition of Ezetimibe and Its Active Metabolites Induced by Impaired Hepatic Function: The Influence of Enzyme and Transporter Activities 期刊论文  OAI收割
PHARMACEUTICS, 2022, 卷号: 14, 期号: 12, 页码: 22
作者:  
Xie, Ningjie;  Wang, Hong;  Qin, Hua;  Guo, Zitao;  Xue, Hao
  |  收藏  |  浏览/下载:20/0  |  提交时间:2023/04/10
Identification of naturally occurring inhibitors in Xian-Ling-Gu-Bao capsule against the glucuronidation of estrogens 期刊论文  OAI收割
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13, 页码: 17
作者:  
He, Liangliang;  Xu, Chunxia;  Wang, Ziying;  Duan, Shuyi;  Xu, Jinjin
  |  收藏  |  浏览/下载:13/0  |  提交时间:2023/04/10
Pharmacokinetics, mass balance, and metabolism of [C-14]TPN171, a novel PDE5 inhibitor, in humans for the treatment of pulmonary arterial hypertension 期刊论文  OAI收割
ACTA PHARMACOLOGICA SINICA, 2022, 页码: 13
作者:  
He, Yi-fei;  Liu, Yin;  Yu, Jing-hua;  Cheng, Huan;  Odilov, Abdullajon
  |  收藏  |  浏览/下载:31/0  |  提交时间:2022/08/16
Pharmacokinetics, Mass Balance, and Metabolism of the Novel Urate Transporter 1 Inhibitor [14C]HR011303 in Humans: Metabolism Is Mediated Predominantly by UDP-Glucuronosyltransferase 期刊论文  OAI收割
DRUG METABOLISM AND DISPOSITION, 2022, 卷号: 50, 期号: 6, 页码: 798-808
作者:  
Zheng, Yuandong;  Zhang, Hua;  Liu, Mengling;  Li, Guangze;  Ma, Sheng
  |  收藏  |  浏览/下载:23/0  |  提交时间:2022/08/16
Intestinal Glucuronidation, Prior to Hepatic Glucuronidation, Plays an Important Role in the Low Circulating Levels of Calycosin 期刊论文  OAI收割
SEPARATIONS, 2022, 卷号: 9, 期号: 5, 页码: 15
作者:  
Jiang, Haodong;  Liu, Huan;  Hu, Pei;  Chen, Shuoji;  Ye, Yaqing
  |  收藏  |  浏览/下载:24/0  |  提交时间:2022/08/16
Absorption, metabolism, and excretion of [C-14]YY-20394, a highly selective PI3K-Delta inhibitor in humans 期刊论文  OAI收割
XENOBIOTICA, 2022, 页码: 11
作者:  
Yu, Jinghua;  Zhang, Hua;  Zhang, Yifan;  Zhan, Yan;  Ma, Sheng
  |  收藏  |  浏览/下载:36/0  |  提交时间:2022/06/15
Quantification of the major circulating metabolite of BS1801, an ebselen analog, in human plasma 期刊论文  OAI收割
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2022, 卷号: 212, 页码: 10
作者:  
Tian, Qianqian;  Jiang, Jinfang;  Yin, Hanwei;  Ma, Jiao;  Deng, Guozhen
  |  收藏  |  浏览/下载:25/0  |  提交时间:2022/06/15